DIRS.INFO top alerts submit data jurnalism about API
login
Top related persons:
Andrew Levin - 3 Rebecca Vogt - 2 Handout - 2 Wegovy - 2 Vogt - 2 Jayson Dallas - 2 Noushin Irani - 2 Mounjaro - 2
Top related locs:
Irving , New York U.S GLP Buffalo , New York United States Dallas Baltimore , Maryland Denmark
Top related orgs:
REUTERS - 2 Nordisk's - 2 Food and Drug Administration - 2 U.S - 2 Rivus Pharmaceuticals - 2 Investors - 2 Deutsche - 2 FDA - 2

Search resuls for: "Andrew Levin"


7 mentions found


☆ How the Fed’s quest for transparency made markets more volatile
  + stars: | 2024-05-11 | by ( Merritt Enright | ) www.cnbc.com   time to read: +2 min
Markets typically respond to Fed comments with price swings in either direction, and recent research shows they are particularly reactive to Powell. And given the Fed's "data-dependent" approach, the baseline can change rapidly as new economic reports are released. "So now we're stuck with a system where there's only one view, there's only one outlook, it's a baseline outlook. And there's really no way to understand the Fed's thinking about where are the risks." Watch the video above to learn more about how the Fed's busy speaking schedule can create market volatility and how it balances transparency with market impact.
Persons: Jerome Powell, Powell, Andrew Levin, —, Levin, Ben Bernanke Organizations: Fed, Federal, Center for Economic Policy Research, Dartmouth College, Federal Reserve Locations: Federal, what's
☆ Focus: Biotech firms target weight-loss drugs without Wegovy's side-effects
  + stars: | 2023-07-07 | by ( Maggie Fick | ) www.reuters.com   time to read: +8 min
[1/7] Rebecca Vogt, a former user of the weight-loss drug Wegovy, poses for a photo, in Irving, New York, U.S., June 20, 2023. It leads to 22.5% weight loss, according to a Lilly trial published last year. An even earlier stage biotech firm, Antag Therapeutics in Denmark, told Reuters that the ballooning obesity market has improved its fundraising prospects. It curbs appetite by restoring the natural release of GLP-1 and other hormones, without causing nausea, Phase I data showed. The effect of the drug on weight loss is being tested in the Phase II study.
Persons: Rebecca Vogt, Handout, Wegovy, Vogt, Jayson Dallas, Noushin Irani, Mounjaro, Eli Lilly's, Lilly, Andrew Levin, Rivus, Mark Fineman, Ashish Nimgaonkar, Nimgaonkar, Alexander Sparre, Ulrich, Tim Opler, Opler, Stifel, Maggie Fick, Josephine Mason, Daniel Flynn Organizations: REUTERS, Nordisk's, Food and Drug Administration, U.S, Reuters, Rivus Pharmaceuticals, Investors, Deutsche, FDA, Pfizer, Capital Management, Rivus, Therapeutics, Johns Hopkins University, pharma, Antag Therapeutics, Aphaia Pharma, Thomson Locations: Irving , New York, U.S, GLP, Buffalo , New York, United States, Dallas, Baltimore , Maryland, Denmark, Switzerland
☆ Weight loss without Wegovy’s side-effects on biotech firms' radar
  + stars: | 2023-07-07 | by ( Maggie Fick | ) www.reuters.com   time to read: +8 min
It leads to 22.5% weight loss, according to a Lilly trial published last year. The effect achieves far more weight loss than predecessors. An even earlier stage biotech firm, Antag Therapeutics in Denmark, told Reuters that the ballooning obesity market has improved its fundraising prospects. It curbs appetite by restoring the natural release of GLP-1 and other hormones, without causing nausea, Phase I data showed. The effect of the drug on weight loss is being tested in the Phase II study.
Persons: Rebecca Vogt, Handout, Wegovy, Vogt, Jayson Dallas, Noushin Irani, Mounjaro, Eli Lilly's, Lilly, Andrew Levin, Rivus, Mark Fineman, Ashish Nimgaonkar, Nimgaonkar, Alexander Sparre, Ulrich, Tim Opler, Opler, Stifel, Maggie Fick, Josephine Mason, Daniel Flynn Organizations: REUTERS, Nordisk's, Food and Drug Administration, U.S, Reuters, Rivus Pharmaceuticals, Investors, Deutsche, FDA, Pfizer, Capital Management, Rivus, Therapeutics, Johns Hopkins University, pharma, Antag Therapeutics, Aphaia Pharma, Thomson Locations: Irving , New York, U.S, GLP, Buffalo , New York, United States, Dallas, Baltimore , Maryland, Denmark, Switzerland
☆ Yellen, caught between financial markets and US Congress, pleases neither
  + stars: | 2023-03-23 | by ( Heather Timmons David Lawder | Heather Timmons | David Lawder | ) www.reuters.com   time to read: +4 min
It's something that the Treasury and regulators did in the depths of the 2008 global financial crisis, but regulatory reforms in 2010 required a streamlined approval from Congress. Meanwhile, hardline Republicans oppose any increase in the current $250,000 Federal Deposit Insurance Corp insurance limit. Yellen explained to the U.S. Senate on March 16 that there would be no guarantee for deposits in banks not deemed a systemic threat, spooking community banks. A temporary systemwide deposit guarantee is needed to stop the bleeding," Ackman said on Twitter after Yellen's testimony to a Senate committee on Wednesday. Yellen is due to testify later on Thursday before the U.S. House of Representatives Appropriations Subcommittee on Financial Services and General Government.
☆ US Sen. Scott pushes for new Fed inspector general, slams Fed over bank regulation,
  + stars: | 2023-03-21 | by ( David Morgan | ) www.reuters.com   time to read: +3 min
Senator Rick Scott said on Monday he will introduce legislation to create an independent inspector general to oversee the Federal Reserve, as he called the U.S. central bank "unable or unwilling to properly regulate" banks in a letter to Fed Chair Jerome Powell. "I am proposing legislation to establish a presidentially-appointed and Senate-confirmed inspector general for the Federal Reserve," Scott told Powell in the letter. The Federal Reserve is responsible for supervising - monitoring, inspecting and examining - certain financial institutions to ensure that they comply with rules and regulations, and that they operate in a safe and sound manner. Scott's legislation stems from concern in Congress that the Federal Reserve's current inspector general is not independent enough to serve as a check on the central bank. Scott also urged the Fed chief to use the central bank's policy meeting this week to examine the bank failures and identify accountable Fed personnel.
☆ The 2023 Madness Machine: Create Your NCAA Bracket
  + stars: | 2023-03-13 | by ( Andrew Levinson | Dov Friedman | Laine Higgins | ) www.wsj.com   time to read: 1 min
This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contact Dow Jones Reprints at 1-800-843-0008 or visit www.djreprints.com. https://www.wsj.com/articles/march-madness-machine-ncaa-bracket-generator-78de0d13
☆ Only a handful of psychedelics companies have gotten funding from established biotech investors. Here's what they've done right, according to a top VC.
  + stars: | 2022-11-22 | by ( Yeji Jesse Lee | ) www.businessinsider.com   time to read: +4 min
RA Capital is one of the few mainstream biotech VCs wading into the psychedelics space. The number of companies touting the benefits of psychedelics for healthcare is rapidly growing, but not all biotech investors are on board yet. Last year RA Capital made two investments into the psychedelics spaceIn 2021, RA made its first investments into the psychedelics space by funding two startups: GH Research and Delix Therapeutics. Dublin, Ireland-based GH Research is one of the only psychedelics companies to have garnered a flurry of interest from mainstream healthcare investors including RA Capital, RTW Investments, and BVF Partners. Lusaris' treatment is designed to be taken sublingually — placed under the tongue — for treatment-resistant depression.
0 next >>
Total: 7